Intellectual Consortium of Drug Discovery and Technology Development Inc.
The editors of journals welcome concise articles devoted to their specialties. Articles must be contributed solely to The journals and become the property of the publisher. Statements contained therein are the responsibility of theauthor(s). The publisher reserves copyright and renewal on all publishedmaterial, and such material may not be reproduced in any form without thewritten permission of the publisher.
• Submission Guidelines at a Glance
• Manuscript Submission Check list
Manuscripts
Address manuscripts to Editor-in-Chief, managing editor or editors of TheJournal of Applied Pharmacy. All submissions should be formatted for Lettersize (8.5 X 11 inches) and may be submitted through the Journal's online submission.
Accepted manuscripts may be published online . Online articles are fully searchable through certain indexing/ abstracting and other services.
A cover letter, signed by the first author and corresponding author, shouldaccompany the manuscript. It should include the name, mailing address,telephone and FAX numbers, and e-mail address of the corresponding author.
In the cover letter and on the title page, indicate the type of manuscript youare submitting: Clinical Research Study, Review, Updates in Office Management,Images in Dermatology, Images in Radiology, Diagnostic Dilemma, ECG Image ofthe Month, Brief Observation, Clinical Communication to the Editor, Letter tothe Editor, Editorial, Commentary, Medical Humanities, Physical Findings,Clinical Effectiveness, or APM Perspectives. Suggestions for potentialreviewers are welcome. Case reports focusing on one patient should be submittedas Clinical Communications to the Editor. Research studies that involve fewerthan 100 subjects should be submitted as Brief Observations. The editorsreserve the right to change the article type. Please refer to the specific wordlimits, formatting guidelines and instructions for each article type beforesubmission.The cover letter must attest that the manuscript represents original work, and that it is not under consideration for publication elsewhere.
The cover lettershould also state all authors meet criteria for authorship and that the authorswill sign a statement attesting authorship, disclosing all potential conflictsof interest, and releasing the copyright should the manuscript be acceptablefor publication.
Potential conflicts of interest for all authors should be discussed in aseparate document. An electronic cover letter from the corresponding author isacceptable. Authors of research articles should disclose any affiliation withany organization with a financial interest, direct or indirect, in the subjectmatter or materials discussed in the manuscript (ie, consultancies, employment,expert testimony, honoraria, retainers, stock) that may affect the conduct orreporting of the work submitted. If uncertain as to what might be considered apotential conflict of interest, authors should err on the side of fulldisclosure. Because reviews and editorials are based on selection andinterpretation of the literature, the Journal expects that authors of sucharticles will not have any financial interest in a company (or its competitor)that makes a product discussed in the article. Information about potential conflict of interest will be made available to reviewers and will be published with the manuscript at the discretion of the editors.
Each author must have participated in the writing of the manuscript, and have seen and approved the submitted version. Further, each author should have beeninvolved in the conception and design of the study, or the analysis of thedata.
Potential authors who have questions about these issues should contact the editorial office of respective journal or at icdtdi@gmail.com.
All correspondence between the Journal's editorial office and the authors will be sent to the corresponding author only.
Text
Use the Style Guide of the American Medical Association as a reference.
Limit use of acronyms or abbreviations to those that are generally accepted (ie, DNA, MRI, STD, HIV, units of measurement, etc.) Measurements of length, height, weight, and volume should be reported in metric units (meter, kilogram, liter) or their decimal multiples. Temperatures should be given in degrees Celsius. Blood pressures should be given in millimeters of mercury.Cite in numerical order every reference, figure, and table. (Order of mention in text determines the number given to each.)
Acknowledgments, including grant support, should be placed at the end of the
text.Please put the manuscript number on all revisions and include it in all correspondence.
References
Number in order of mention. Provide complete concluding page numbers for all journal references and specific page numbers for all book references. Indicate all abstracts and letters.Follow general arrangement, abbreviations, and punctuation as given in requirements for manuscripts submitted to ICDTD Inc. journals. For periodicals,follow INDEX MEDICUS, listing all authors when four or fewer; when five ormore, list only first three and add et al. Personal communications are discouraged. If included, they must be notedparenthetically in the text, dated by month and year, and accompanied by awritten acknowledgment.Please note that no periods are used after authors' initials.
Tables
Start each table at top of new page.Give each table a title. Number them (in arabic numerals, Table 1, 2, etc.) inthe order in which they are mentioned in the text.Provide a footnote to each table, identifying all abbreviations used.
Figures and Figure Legends
All figures should be submitted electronically through the online submission system.
Photographs should be tiff files of 300dpi or greater.
High-quality jpg files are also acceptable.
Please note that artwork of published articles will not be returned.Use black ink for all charts (line drawings). Make decimals, broken lines,etc., strong enough for eproduction.All lettering should be of approximately equal size.Use arrows to designate special features.Titles should be included in the figure legend, not in the figure. Number figures in order in which they are mentioned in the text, using arabic numerals (Figure 1, 2, etc.).
Identify at the end of each legend all abbreviations used in the figure.Indicate staining method and magnification for all photomicrographs.If figure legends are submitted separately from the figures, they should be listed in order on a single page.Submit written permission from publisher and author to reproduce any previously published figures.
Submission
Send the soft copy of your manuscripts along with cover letter, undertaking and statement of no conflict of interest at submission@icdtdi.ca
Rapid Review
The editors will try to make a preliminary decision concerning the potential suitability of a manuscript for the Journal within a few days, and to obtain peer review expeditiously. Electronic submission of manuscripts will facilitate this process.
Conflict of interest for journal purposes
The conflict of interest during the publication process occurs when influences other than science result in an article being either rejected or published with results or discussion, that misleads the reader. This may ultimately result ina significant disservice to our customers, community or institutions orpatients.The conflict of interest is usually thought to be financial and while this isfrequently the case there are other ways that conflict can arise in thedevelopment, review and publication of a an article. For example, conflict canoccur if there is a strong positive or negative bias toward the authors on thepart of the reviewers of the editor handling the manuscript. For the purpose of this statement, an article is defined as any communication in the journal;including original articles, communications-in-brief, case reports, clinical opinions, reviews, letters to the editor and replies as well as editorials. The editors of Journal of Applied Pharmacy feel strongly that stringent guidelines must be present for each step of the development, evaluation and publication process.
Responsibilities of the Authors
The authors of all articles must inform the editors of any possible conflict of interest. This includes any financial interest the authors may have in the company producing products described in the article; as well as stock options,direct employment, consulting status or membership in a speaker’s bureau. Themonetary value should be stated explicitly. Failure to do so may result insignificant sanctions. The editor will decide what potential conflicts must bedisclosed to the reader. They will be listed on the first page of the article.Authors should not knowingly recommend as a potential reviewer a person with potential conflict of interest either financial or personal positive or negative bias (i.e. mentor or close personal association).
Responsibilities of the Reviewer
Reviewers must disclose any financial interest they have in the companies producing pharmaceuticals, supplies or equipment to the medical profession.Such financial interest includes stock, direct employment, stock options,consultant or membership in a speaker’s bureau. Reviewers should not accept anassignment if they have prior or current close relationships (mentor orcolleague) with the authors. Reviewers should not accept the assignment if there is a competitive relationship with or a negative bias toward the authors.
Responsibilities of the Editor
The financial relationship of the editors should be filed with the editorial office and updated annually. The editor should not handle a manuscript if thereis a potential conflict of interest. This includes financial interest as wellas positive or negative biases toward the author or companies producingmaterials described in the article. The editors must decide which conflicts disclosed by the author will be listed with the article.
e-First Article
The accepted articles are posted here immediately to provide more rapid publication and better access to the scientists. These manuscripts have notbeen professionally edited and do not appear as they will in the final journalissue. The approved final manuscripts will be compiled in the quarterly onlineversions of Journal of Applied Pharmacy.